Last updated: 23 August 2024 at 4:45pm EST

Dr. Mahkam Zanganeh D.D.S., M.B.A., MBA Net Worth




The estimated Net Worth of Mahkam Zanganeh is at least $1.59 Million dollars as of 26 March 2024. Dr Zanganeh owns over 110,321 units of Summit Therapeutics Inc stock worth over $1,135,000 and over the last 8 years he sold SMMT stock worth over $0. In addition, he makes $459,377 as COO & Director at Summit Therapeutics Inc.

Dr MBA SMMT stock SEC Form 4 insiders trading

Dr has made over 15 trades of the Summit Therapeutics Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 110,321 units of SMMT stock worth $411,497 on 26 March 2024.

The largest trade he's ever made was buying 23,527,044 units of Summit Therapeutics Inc stock on 8 March 2023 worth over $24,703,396. On average, Dr trades about 791,433 units every 68 days since 2017. As of 26 March 2024 he still owns at least 50,000 units of Summit Therapeutics Inc stock.

You can see the complete history of Dr Zanganeh stock trades at the bottom of the page.





Dr. Mahkam Zanganeh D.D.S., M.B.A., MBA biography

Dr. Mahkam Zanganeh D.D.S., M.B.A., MBA is the COO & Director at Summit Therapeutics Inc.

What is the salary of Dr MBA?

As the COO & Director of Summit Therapeutics Inc, the total compensation of Dr MBA at Summit Therapeutics Inc is $459,377. There are no executives at Summit Therapeutics Inc getting paid more.



How old is Dr MBA?

Dr MBA is 51, he's been the COO & Director of Summit Therapeutics Inc since . There are 5 older and 2 younger executives at Summit Therapeutics Inc. The oldest executive at Summit Therapeutics Inc is Robert W. Duggan, 77, who is the Co-CEO & Exec. Chairman.

What's Dr MBA's mailing address?

Mahkam's mailing address filed with the SEC is C/O SUMMIT THERAPEUTICS INC., 601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131.

Insiders trading at Summit Therapeutics Inc

Over the last 4 years, insiders at Summit Therapeutics Inc have traded over $0 worth of Summit Therapeutics Inc stock and bought 529,946,601 units worth $632,334,967 . The most active insiders traders include Robert W Duggan, Mahkam Zanganeh, and Manmeet Singh Soni. On average, Summit Therapeutics Inc executives and independent directors trade stock every 77 days with the average trade being worth of $751,966,329. The most recent stock trade was executed by Mahkam Zanganeh on 26 March 2024, trading 110,321 units of SMMT stock currently worth $411,497.



What does Summit Therapeutics Inc do?

summit is a uk company focused on the discovery and development of novel drug candidates to treat areas of high unmet medical need. our strategy focuses on two therapy areas: duchenne muscular dystrophy, a fatal genetic muscle wasting disease and the infectious disease caused by the bacteria c. difficile.



What does Summit Therapeutics Inc's logo look like?

Summit Therapeutics Inc logo

Complete history of Dr Zanganeh stock trades at Pulse Biosciences Inc and Summit Therapeutics Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
26 Mar 2024 Mahkam Zanganeh
Chief Executive Officer
Buy 110,321 $3.73 $411,497
26 Mar 2024
50,000
11 Dec 2023 Mahkam Zanganeh
Chief Executive Officer
Buy 5,000 $2.07 $10,350
11 Dec 2023
494,814
8 Mar 2023 Mahkam Zanganeh
Chief Executive Officer
Buy 23,527,044 $1.05 $24,703,396
8 Mar 2023
9,884,095
16 Aug 2022 Mahkam Zanganeh
Chief Executive Officer
Buy 5,809,132 $0.97 $5,634,858
16 Aug 2022
3,135,466
12 May 2021 Mahkam Zanganeh
Chief Executive Officer
Buy 389,077 $5.24 $2,038,763
12 May 2021
2,643,319
13 Nov 2023 Mahkam Zanganeh
Director
Option 76,075 $2.14 $162,801
13 Nov 2023
604,911
23 Jun 2020 Mahkam Zanganeh
Director
Buy 1,193 $10.70 $12,765
23 Jun 2020
106,767
17 Jun 2020 Mahkam Zanganeh
Director
Buy 7,950 $7.01 $55,730
17 Jun 2020
105,574
13 Dec 2017 Mahkam Zanganeh
Director
Buy 1,100 $23.98 $26,378
13 Dec 2017
95,574
11 Dec 2017 Mahkam Zanganeh
Director
Buy 4,000 $23.07 $92,280
11 Dec 2017
94,474
14 Sep 2017 Mahkam Zanganeh
Director
Buy 29,775 $13.36 $397,794
14 Sep 2017
332,500
2 Aug 2017 Mahkam Zanganeh
Director
Buy 28,790 $23.96 $689,808
2 Aug 2017
90,474
9 May 2017 Mahkam Zanganeh
Director
Buy 53,760 $20.49 $1,101,542
9 May 2017
85,474
17 Mar 2017 Mahkam Zanganeh
Director
Buy 18,240 $23.34 $425,722
17 Mar 2017
46,714
15 Feb 2017 Mahkam Zanganeh
Director
Buy 13,000 $11.97 $155,610
15 Feb 2017
33,474


Summit Therapeutics Inc executives and stock owners

Summit Therapeutics Inc executives and other stock owners filed with the SEC include: